Paper Title
Stability Indicating Analytical Method Development and Validation for Molnupiravir in Human Plasma
Article Identifiers
Authors
Vaibhav Vilas Narwade , Madhuri D. Game
Keywords
RP-HPLC, Molnupiravir, Method Development, Validation
Abstract
This study presents a robust and validated reverse-phase high-performance liquid chromatography (RP-HPLC) method for the quantification of Molnupiravir, an antiviral drug used in the treatment of COVID-19. The method was developed and optimized using a C18 column with a mobile phase consisting of methanol and sodium acetate buffer. System suitability tests demonstrated the appropriateness of the chromatographic system, ensuring precision, resolution, and peak symmetry. The method exhibited excellent specificity, as evidenced by the matching retention times of standard and test samples. Linearity was confirmed over a concentration range of 15-45 µg/ml, with a correlation coefficient (R²) of 0.9995. Accuracy studies revealed recoveries ranging from 99.81% to 101.91%, indicating the method's reliability. Precision assessments, including intra-day and inter-day variations, demonstrated reproducibility with %RSD values within acceptable limits. Additionally, the method showed adequate sensitivity, with limits of detection (LOD) and quantification (LOQ) of 1.04 µg/ml and 3.17 µg/ml, respectively. Robustness studies indicated that small variations in method parameters did not significantly affect assay results. Stability studies under various stress conditions demonstrated the drug's susceptibility to degradation under acidic conditions while showing stability under other conditions. Overall, the validated RP-HPLC method offers a simple, accurate, and precise means for the routine analysis of Molnupiravir, contributing to the effective management of COVID-19 treatment protocols.
Downloads
How To Cite (APA)
Vaibhav Vilas Narwade & Madhuri D. Game (May-2024). Stability Indicating Analytical Method Development and Validation for Molnupiravir in Human Plasma. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(5), d739-d748. https://ijnrd.org/papers/IJNRD2405383.pdf
Issue
Volume 9 Issue 5, May-2024
Pages : d739-d748
Other Publication Details
Paper Reg. ID: IJNRD_218945
Published Paper Id: IJNRD2405383
Downloads: 000121981
Research Area: Pharmacy
Country: Hingoli, Maharashtra, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2405383.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2405383
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition


Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.
Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: October 2025
Current Issue: Volume 10 | Issue 10 | October 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-Oct-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details